BRLF1-EBV的一种立即早期基因的研究进展
被引量:2
A Review Research Progress of BRLF1 One of EBV Immediate-Early Gene
摘要
BRLF1是EBV的立即早期基因。作为一种反式激活因子,它可以调节EBV早期/晚期基因的表达,并且还可能参与裂解期病毒基因组的复制。它的表达与EBV潜伏周期向裂解周期的转换密切相关。BRLF1的蛋白产物Rta包含CTL识别的表位,可能在病毒裂解周期的早期成为免疫系统的作用位点。对它研究还可能为某些EBV相关肿瘤的筛查和治疗提供线索。
出处
《中国肿瘤》
CAS
2005年第6期372-375,共4页
China Cancer
参考文献30
-
1Furnari FB, Zacny V, Quinlivan EB,et al. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism [J]. J Virol,1994, 68:1827-1836.
-
2Chang PJ, Liu ST. Function of the intercistronic region of BRLF1 BZLF1 bicistronic mRNA in translating the Zta protein of epstein-Barr virus[J]. J Virol,2001,75:1142-1151.
-
3Chang PJ, Chang YS, Liu ST. Role of Rta in the translation of bi cistronic BZLF1 of Epstein-Barr virus [J]. J Virol,1998,72:5128-5136.
-
4Ragoczy T, Miller G. Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Spl and Sp3 binding sites [J]. J Virol,2001,75:5240-5251.
-
5Zalani S, Holley-Guthrie E, Gutsch D,et al.The Epstein -Barr virus immediate-early promoter BRLF1 can be activated by the cellular Spl transcription factor [J].J Virol,1992,66:7282-7292.
-
6Zalani S, Holley-Guthrie E, Kenney S.The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter [J].J Virol,1995,69:3816-3823.
-
7Zalani S,Coppage A,Holley-Guthrie E, et al.The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter[J].J Virol, 1997,71:3268-3274.
-
8Kraus R, PeiTigoue J, Mertz J. ZEB negatively regulates the lyric-switch BZLF1 gene promoter of Epstein-Barr virus[J]. J Virol,2003,77:199-207.
-
9Liu PF,Speck SH. Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta[J]. Virology,2003,310:199-206.
-
10Hardwick JM, Tse L, Applegren N,et al. The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16 [J]. J Virol, 1992,66:5500-5508.
同被引文献22
-
1张玉,郜红艺,冯惠霞,邓玲,黄马燕,胡斌,程钢,吴秋良,崔念基,邵建永.鼻咽癌病人血浆和外周血白细胞EB病毒DNA定量分析[J].中华医学杂志,2004,84(12):982-986. 被引量:16
-
2Wille CK, Nawandar DM, Panfil AR, et al. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication. J Virol,2013 ,87 :935-950.
-
3Cheng WM, Chan KH, Chen HL, et al. Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int J Cancer, 2002,97:489 -492.
-
4Mutirangura A, Pomthanakasem W, Theamhoonlers A, et al. Epstein-Ban" viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res,1998, 4:665-669.
-
5Feng P, Cban SH, Soo MY, et al. Antibody response to Epstein- Barr virus Rta protein in patients with nasopharyngeal carcinoma:a new serologic parameter for diagnosis. Cancer, 2001, 92: 1872-1880.
-
6Sener AG, Afsar I, Pinar E. Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state. J Virol Methods, 2009,159:300-302.
-
7E1-Guindy A, Ghiassi-Nejad M, et al. Essential role of Rta in lytic DNA replication of Epstein-Ban" virus[J]. J Virol, 2013, 87( 1 ) : 208-223.
-
8Feng P, Chan SH, Soo MY, et al. Antibody response to Epstein- Ban" virus Rta protein in patients with nasopharyngeal carcinoma: a new serologic parameter for diagnosis [ J . Cancer, 2001,92 ( 7 ) : 1872-1879.
-
9Livak K J, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 -CT method [ J ]. Methods, 2001,25(4) :402-408.
-
10Wille CK, Nawandar DM, Panfil AR, et al. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1to activate Epstein-Ban" virus lytic gene expression and viral replication[J]. J Virol,2013,87(2) : 935-950.
引证文献2
-
1罗耀凌,陈浩,彭颂国,林建华,黄培钰.联合检测EB病毒不同抗体及EB病毒DNA在鼻咽癌血清学诊断中的价值[J].中华医学杂志,2013,93(44):3516-3519. 被引量:49
-
2赵新星,张龙城,全超坤,韦干观,桂源,杨志.EB病毒BRLF1基因及EB病毒Rta/IgG抗体在鼻咽癌中表达的临床意义[J].中国眼耳鼻喉科杂志,2016,16(4):243-247. 被引量:7
二级引证文献56
-
1宋鹏,林端,陈艳丽,魏日富,刘接威.HIF1-α和PCDGF在鼻咽癌诊断和预后评价中的临床价值研究[J].现代生物医学进展,2019,19(24):4789-4792. 被引量:1
-
2肖立云.颈部食管造口术对鼻咽癌放疗后重度吞咽困难患者提高营养和生活质量的观察[J].世界临床医学,2017,11(6):82-82. 被引量:2
-
3唐国文.广州地区鼻咽癌患者非职业相关因素的调查[J].国际医药卫生导报,2014,20(13):2017-2019. 被引量:3
-
4王盼盼,季明芳,吴标华.鼻咽癌高发区人群患鼻咽癌风险率的动态观察[J].中华肿瘤防治杂志,2014,21(15):1144-1147. 被引量:16
-
5俞霞,季明芳,程伟民,李星华,吴标华,何秀芳.鼻咽癌高危人群血浆EBV-DNA定量分析[J].中华肿瘤防治杂志,2014,21(17):1309-1312. 被引量:12
-
6张晓琍,周建林,曹颖平.鼻咽癌筛查中三种EB病毒抗体检测的应用[J].中华检验医学杂志,2015,38(2):111-114. 被引量:29
-
7李志勇,杨荃荃,吉爽,彭涛,冯俊.EBV-DNA定量检测在鼻咽癌随访中的意义[J].国际病毒学杂志,2015,22(4):281-285. 被引量:11
-
8朱亮华,金蕊,周国平,蒋莉.传染性单核细胞增多症患儿外周血IRF-3和Rta表达水平及其相关性分析[J].江苏医药,2015,41(17):2023-2024. 被引量:2
-
9郭俊英,陈艳,陈燕,李筱莉,肖景荣,郑瑜宏.福州市体检人群EB病毒VCA-IgA、EA-IgA和Rta-IgG调查分析[J].标记免疫分析与临床,2015,22(12):1200-1203. 被引量:8
-
10张凤久,顾建华,宋柏龙,万会,马智杰,邱会军,孙勇,许栋岳.EB病毒检测对鼻咽癌诊断的临床意义[J].国际病毒学杂志,2015,22(6):408-410. 被引量:2
-
1综述列题[J].中国医学文摘(肿瘤学),2005,19(4):304-305.
-
2任军,张晓梅,张晓光,李红霞,周玲,曾毅.以Rtac2/3为抗原用于鼻咽癌病人检测的初步研究[J].中华微生物学和免疫学杂志,2006,26(11):1057-1059. 被引量:31
-
3郑琳,李怀斌,贾明华.大肠癌中Smad4、uPA、PAI-1的表达及意义[J].中国误诊学杂志,2005,5(4):615-618.
-
4柏华,胡国刚,魏慧娟,罗贤懋.c-fos基因表达调控与细胞增殖分化和癌变的关系[J].中国实验动物学杂志,1997,7(1):38-41. 被引量:1
-
5赵新星,张龙城.鼻咽癌与EB病毒立即早期蛋白的应用进展[J].临床耳鼻咽喉头颈外科杂志,2016,30(13):1078-1083. 被引量:8
-
6宋新兰(综述),孙振柱(审校).EB病毒与霍奇金淋巴瘤相关性的研究进展[J].世界肿瘤杂志,2006,5(3):212-215. 被引量:1
-
7张青竹,王云,罗兵.EB病毒即刻早期BRLF1基因在淋巴瘤组织中多态性研究(英文)[J].现代生物医学进展,2013,13(26):5030-5036. 被引量:1
-
8姜华.EB病毒特异性细胞毒性T淋巴细胞与肿瘤免疫治疗研究进展[J].国外医学(免疫学分册),2001,24(5):240-243. 被引量:3
-
9董晖,梁伟波,朱银华,张蓓蕾,江华,张林.EB病毒重组Rta蛋白在胃癌组织中表达的研究[J].川北医学院学报,2007,22(2):102-104. 被引量:1
-
10刘保安,蒋晓群,蔡杰,姚开泰.鼻咽癌中EBV DNA的原位检测及其意义的探讨[J].诊断病理学杂志,1997,4(2):83-85. 被引量:1